AVEO Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics. The firm offers products such as Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353.
| Website: | www.aveooncology.com |
| Email: | ir@aveooncology.com |
| Main Phone: | +1 617 588-1960 |
| Address: | One Broadway |
| Address 2: | 14th Floor |
| State: | MA |
| City / Town: | Cambridge |
| Country: | USA |
| Postal Code: | 02142 |
| Exchange: | NSC |
| CEO: | Michael P. Bailey |
| Employees: | 19 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 2.88 | Change $ 0.01 | Change % 0.35 | Tick N/A |
| Bid 2.88 | Bid Size 1,500.00 | Ask 2.89 | Ask Size 5,100.00 |
| Open 2.87 | High 2.94 | Low 2.83 | Prev Close 2.87 |
| Last Trade | Volume 985,389 | 52 Wk Hi 4.15 | 52 Wk Low 1.86 |
| Market Cap 342.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 119,030,147.00 | EPS (TTM) -0.30 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 72 | 74 |
| Number of Buys | 72 | 72 |
| Number of Sells | 0 | 2 |
| Net Activity | 11057427 | 11005613 |
| Last 10 Buys | Shares |
|---|---|
| David M. Mott | 1,000 |
| Peter Sonsini | 1,000 |
| Jon Sakoda | 1,000 |
| Forest Baskett | 1,000 |
| Sandell D Scott | 1,000 |
| Anthony A. Florence | 1,000 |
| Peter J. Barris | 1,000 |
| Ravi Viswanathan | 1,000 |
| Joshua Makower | 1,000 |
| Ravi Viswanathan | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Matthew Dallas | 1,000 |
| Michael P. Bailey | 1,000 |
| Matthew Dallas | 1,000 |
| Joseph Vittiglio | 1,000 |
| Jeno Gyuris | 1,000 |
| Joseph Vittiglio | 1,000 |
| Jeno Gyuris | 1,000 |
| William Slichenmyer | 1,000 |
| Michael P. Bailey | 1,000 |
| David Johnston | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 7 | 7 | 7 | 7 |
| Low Target Price Estimate | 5 | 5 | 5 | 5 |
| Mean Target Price Estimate | 5.67 | 5.67 | 5.67 | 5.67 |
| Standard Deviation | 1.15 | 1.15 | 1.15 | 1.15 |
| Date of Most Recent Estimate | 05/08/18 | 05/08/18 | 05/08/18 | 05/08/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
